Integral Diagnostics Limited (ASX:IDX)

Market Cap	867.57M +8.6%
Revenue (ttm)	767.82M +56.3%
Net Income	14.03M +147.8%
EPS	0.04 +59.8%
Shares Out	372.35M
PE Ratio	62.11
Forward PE	16.35
Dividend	0.07 (2.83%)
Ex-Dividend Date	Mar 4, 2026

Volume	726,866
Average Volume	1,244,354
Open	2.350
Previous Close	2.330
Day's Range	2.350 - 2.400
52-Week Range	2.110 - 3.070
Beta	0.14
RSI	42.77
Earnings Date	Feb 23, 2026

About Integral Diagnostics

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1967
• Employees: 3,000
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IDX